Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-06

Clinical Trial Update: EMPower Mechanisms [NA]

View source ↗

Summary

A clinical trial update indicates EMPower Mechanisms (NCT06861465) is recruiting for Primary Biliary Cholangitis at the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Primary Biliary Cholangitis (PBC) | NA | Status: RECRUITING